Skip to main content

LA Thrombus Classification

 

Classification of Left Atrial (LA) Thrombus

Left atrial thrombus is a clinically significant finding, most commonly associated with atrial fibrillation, rheumatic mitral valve disease, and severe left ventricular dysfunction. Proper classification helps guide anticoagulation, cardioversion planning, and interventional strategy.



---


1. Classification Based on Location


A. Left Atrial Appendage (LAA) Thrombus


Most common site (>90% in non-valvular AF)


Best visualized on TEE


Often associated with:


Atrial fibrillation


Low LAA emptying velocity (<20 cm/s)


Spontaneous echo contrast (“smoke”)




Clinical significance: Contraindication to cardioversion and catheter ablation until resolved.



---


B. Left Atrial Body Thrombus


Seen in:


Rheumatic mitral stenosis


Severely dilated LA



May be mural or mobile


Higher embolic risk if pedunculated or mobile



More common in valvular AF compared to non-valvular AF.



---


2. Classification Based on Mobility


1. Mural (Non-mobile) Thrombus


Attached along LA wall


Broad-based


Lower embolic potential compared to mobile thrombi



2. Pedunculated / Mobile Thrombus


Attached by a stalk


Oscillates within LA cavity


High embolic risk


May mimic atrial myxoma




---


3. Classification Based on Morphology (Echocardiographic Appearance)


A. Fresh (Recent) Thrombus


Hypoechoic or isoechoic


Soft appearance


May be associated with dense spontaneous echo contrast



B. Organized (Chronic) Thrombus


More echogenic


Firm and well-defined


May show layered appearance



Chronic thrombi may partially endothelialize.



---


4. Classification Based on Underlying Etiology


A. Non-Valvular AF


Mostly LAA thrombus


Associated with CHA₂DS₂-VASc risk factors



B. Valvular AF (e.g., Rheumatic MS)


LA body thrombus more common


Larger clot burden



C. Post-Cardiac Surgery or Device-Related


Around prosthetic valves


Along LA walls or closure devices




---


5. Special Classification: Type I vs Type II LA Thrombus (Rheumatic MS Context)


Type I: Confined to LAA


Type II: Extends into LA cavity



Type II carries higher embolic risk and procedural complications during balloon mitral valvotomy.



---


Imaging Modalities for Classification


Transthoracic Echo (TTE): Limited sensitivity for LAA


Transesophageal Echo (TEE): Gold standard


Cardiac CT: Useful when TEE contraindicated


Cardiac MRI: Tissue characterization




---


Key Clinical Implications


Presence of LA thrombus = defer elective cardioversion


Requires therapeutic anticoagulation (usually ≥3–4 weeks before reassessment)


Repeat TEE to confirm resolution


Persistent thrombus may require long-term anticoagulation




---


Summary Table


Basis of Classification Types


Location LAA, LA body

Mobility Mural, Mobile

Morphology Fresh, Organized

Etiology Valvular, Non-valvular, Device-related

Rheumatic MS subtype Type I, Type II

---


Left atrial thrombus classification is not merely academic—it directly influences embolic risk assessment, anticoagulation strategy, and procedural planning in atrial fibrillation and rheumatic mitral stenosis.



Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.